The data showed reduced difficulties in standing, walking and running that were statistically significant, the company said.
Maintaining muscle mass is crucial for health, and researchers have identified the protein BCL6 as vital for this. Studies ...
Late-stage trial data for Roche's drug against muscle-wasting Elevidys showed positive results after two years of treatment for male patients aged 4 or older with Duchenne muscular dystrophy.
Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for ...
Roche and Sarepta Therapeutics have shared positive top-line results from a late-stage study of Elevidys (delandistrogene ...
Joshua Mercieca defied the odds after he was diagnosed with the muscle-wasting condition Duchenne muscular dystrophy at a ...
The health activists argue that the government is empowered with effective law and policy tools and therefore should ...
Deer in Georgia are at risk of contracting a neurological disease with a 100 percent mortality rate. One deer in southern ...
Scientists unveil groundbreaking research on BCL6 protein that could help Ozempic users maintain muscle while losing weight. Here's what you need to know ...